tradingkey.logo

Firefly Neuroscience Inc

AIFF

2.610USD

+0.040+1.56%
Cierre 08/22, 16:00ETCotizaciones retrasadas 15 min
34.71MCap. mercado
PérdidaP/E TTM

Firefly Neuroscience Inc

2.610

+0.040+1.56%
Más Datos de Firefly Neuroscience Inc Compañía
Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company dedicated to developing neuroscientific solutions that enhance outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics (BNA) software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder (ADHD). BNA, utilizing AI and an extensive proprietary electroencephalogram (EEG) database, combines the automatic analysis of Event Related Potentials (ERPs), spectral EEG and behavioral performance data for a comprehensive, and objective data-driven brain health evaluation. The BNA Platform, in conjunction with an FDA-cleared EEG system, can provide clinicians with comprehensive insights into brain function (cognition).
Información de la empresa
Símbolo de cotizaciónAIFF
Nombre de la empresaFirefly Neuroscience Inc
Fecha de salida a bolsaOct 27, 1993
Director ejecutivoMr. Greg Lipschitz
Número de empleados13
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 27
Dirección1100 Military Road
CiudadKENMORE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal14217
Teléfono18882376412
Sitio Webhttps://fireflyneuro.com/
Símbolo de cotizaciónAIFF
Fecha de salida a bolsaOct 27, 1993
Director ejecutivoMr. Greg Lipschitz
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Gil Issachar
Mr. Gil Issachar
Chief Technology Officer
Chief Technology Officer
33.48K
--
Mr. David Decaprio
Mr. David Decaprio
President, Chief Operating Officer, Director
President, Chief Operating Officer, Director
11.10K
--
Mr. Paul Krzywicki, CPA
Mr. Paul Krzywicki, CPA
Chief Financial Officer
Chief Financial Officer
2.50K
--
Mr. Stephen Kilmer
Mr. Stephen Kilmer
Investor Contact
Investor Contact
--
--
Mr. Greg Lipschitz
Mr. Greg Lipschitz
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Brian M. Posner, CPA
Mr. Brian M. Posner, CPA
Independent Director
Independent Director
--
--
Ms. Stella Vnook
Ms. Stella Vnook
Independent Director
Independent Director
--
--
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Gil Issachar
Mr. Gil Issachar
Chief Technology Officer
Chief Technology Officer
33.48K
--
Mr. David Decaprio
Mr. David Decaprio
President, Chief Operating Officer, Director
President, Chief Operating Officer, Director
11.10K
--
Mr. Paul Krzywicki, CPA
Mr. Paul Krzywicki, CPA
Chief Financial Officer
Chief Financial Officer
2.50K
--
Mr. Stephen Kilmer
Mr. Stephen Kilmer
Investor Contact
Investor Contact
--
--
Mr. Greg Lipschitz
Mr. Greg Lipschitz
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Brian M. Posner, CPA
Mr. Brian M. Posner, CPA
Independent Director
Independent Director
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: sáb., 16 de ago
Actualizado: sáb., 16 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Windsor Private Capital LP
11.37%
Johnson (David Ian)
8.33%
Arena Investors, LP
5.97%
RJL 18 Capital Canada LP
3.73%
Roxy Capital Corp.
3.17%
Otro
67.43%
Accionistas
Accionistas
Proporción
Windsor Private Capital LP
11.37%
Johnson (David Ian)
8.33%
Arena Investors, LP
5.97%
RJL 18 Capital Canada LP
3.73%
Roxy Capital Corp.
3.17%
Otro
67.43%
Tipos de accionistas
Accionistas
Proporción
Corporation
23.59%
Individual Investor
15.32%
Investment Advisor/Hedge Fund
7.27%
Investment Advisor
3.34%
Research Firm
0.15%
Hedge Fund
0.01%
Otro
50.32%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
56
6.51M
49.12%
+3.62M
2025Q1
59
6.44M
48.97%
+3.40M
2024Q4
45
5.34M
66.51%
+3.29M
2024Q3
44
4.63M
60.12%
+4.34M
2024Q2
41
392.29K
19.12%
-172.61K
2024Q1
44
378.90K
18.56%
-204.63K
2023Q4
44
402.68K
20.26%
-97.56K
2023Q3
43
439.70K
22.73%
-157.24K
2023Q2
43
553.83K
29.34%
-60.70K
2023Q1
41
566.63K
29.99%
-42.63K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Windsor Private Capital LP
1.52M
11.48%
+1.52M
--
Aug 12, 2024
Johnson (David Ian)
1.12M
8.41%
+557.88K
+100.00%
Oct 22, 2024
Arena Investors, LP
800.00K
6.03%
+800.00K
--
Feb 13, 2025
RJL 18 Capital Canada LP
499.37K
3.77%
+499.37K
--
Aug 13, 2024
Roxy Capital Corp.
424.69K
3.2%
-265.38K
-38.46%
Feb 12, 2025
Lipschitz (Gregory)
401.97K
3.03%
--
--
Mar 25, 2025
Finn (Christopher)
349.22K
2.63%
-85.98K
-19.76%
Dec 31, 2024
Canaccord Genuity Corp
292.77K
2.21%
+292.77K
--
Mar 25, 2025
UBS Financial Services, Inc.
93.63K
0.71%
+77.16K
+468.41%
Mar 31, 2025
Nomis Bay, Ltd.
204.29K
1.54%
--
--
Feb 07, 2025
Ver más
ETFs relacionados
Actualizado: mié., 6 de ago
Actualizado: mié., 6 de ago
Nombre
Proporción
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proporción0%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Oct 17, 2023
Merger
10<1
Oct 17, 2023
Merger
10<1
Oct 17, 2023
Merger
10<1
Oct 17, 2023
Merger
10<1
Fecha
Tipo
Relación
Oct 17, 2023
Merger
10<1
Oct 17, 2023
Merger
10<1
Oct 17, 2023
Merger
10<1
Oct 17, 2023
Merger
10<1
KeyAI